Publications
411
Citations
7,080
Est. group size
~11
Recurring co-author estimate
Active years
47
Publishing since 1980
Moray J. Campbell studies the molecular biology of hormone-related cancers, especially prostate cancer, focusing on how nuclear receptors (like the androgen receptor), chromatin-modifying proteins (such as Kaiso/ZBTB33 and SMARCA5), and gene regulatory networks drive tumor progression, treatment resistance, and disease disparities across different patient populations. The group also investigates how obesity-related fat tissue near the prostate and its released signaling particles (extracellular vesicles) contribute to more aggressive cancer, alongside related work on breast cancer and thyroid-related sodium-iodide symporter biology.
Publication output was relatively steady and modest from 2017–2022, then rose sharply in 2023 before declining again through 2025–2026, though it remains higher than pre-2023 levels.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Peri-prostatic adipose tissue drives obesity-associated prostate cancer aggressivity via extracellular vesicles and Rho GTPase signalling
Endocrine Abstracts · 2026
- Abstract 5922: Single-cell mapping of the colon epithelium reveals a pre-malignant stem cell that defines early transformation risk
Cancer Research · 2026
- Abstract 3229: The chromatin remodeler SMARCA5 displays ancestry-specific functions in African American prostate cancer
Cancer Research · 2026
- Molecular determinants of AR–enhancer interaction and cistrome reprogramming in prostate cancer progression
Endocrine Related Cancer · 2026
- Genomic Crosstalk Between Nuclear Receptors in Hormone-dependent Cancers
Endocrinology · 2025
- Mutant p53 regulates a distinct gene set by a mode of genome occupancy that is shared with wild type
EMBO Reports · 2025
- Extracellular-vesicles from the peri-prostatic adipose tissue of obese, but not lean, men promote prostate cancer aggressivity
Endocrine Abstracts · 2025
- Abstract 4046: Role of kaiso in androgen receptor signaling and castration resistance
Cancer Research · 2025
- Abstract P3-07-21: Transcriptomic analysis of the tumor immune microenvironment (TIME) in patients with breast cancer with liver metastasis (BCLM)
Clinical Cancer Research · 2025
- Abstract C083: Kaiso defines distinct chromatin and protein interaction networks in breast cancer: Implications for precision therapy
Cancer Epidemiology Biomarkers & Prevention · 2025
- Abstract A032: Exploring ZBTB33 (KAISO) binding profiles in aggressive prostate cancer cells
Cancer Epidemiology Biomarkers & Prevention · 2025
- OR30-05 Communication between prostate tumours and periprostatic adipose drives obesity associated prostate cancer aggressivity
Journal of the Endocrine Society · 2025
- ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer
Nucleic Acids Research · 2024
- Whole‐exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways
The Prostate · 2024
- Abstract 7467: Multi-omics analysis reveals high chronic inflammation in African Americans compared to Native African Men with prostate cancer
Cancer Research · 2024
- Cancer Research×21
- bioRxiv (Cold Spring Harbor Laboratory)×10
- Endocrine Abstracts×7
- Cancer Epidemiology Biomarkers & Prevention×7
- Molecular Cancer Therapeutics×3
- Jocelyne N. Hanquier
Medicine · Indiana University
- Hedieh Jafari
Medicine · The Ohio State University
- Timothy H. Helms
Medicine · The Ohio State University
- Craig J. Burd
Medicine · The Ohio State University
- Lara E. Sucheston‐Campbell
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile